PAVmed (PAVM) Long-Term Debt Issuances (2020 - 2023)
PAVmed's quarterly Long-Term Debt Issuances came in at $10.0 million in Q1 2023, down 2.22% quarter-over-quarter from $10.2 million in Q3 2022.
PAVmed has reported Long-Term Debt Issuances for 3 years, with the latest figure at $10.0 million in Q1 2023.
- For the quarter ending Q1 2023, Long-Term Debt Issuances changed N/A year-over-year to $10.0 million; the trailing twelve-month figure through Dec 2023 stood at $10.0 million (down 2.22% YoY), and the FY2023 full-year result was $10.0 million, down 71.61% from the prior year.
- Long-Term Debt Issuances for Q1 2023 stood at $10.0 million, down from $10.2 million in the prior quarter.
- The five-year high for Long-Term Debt Issuances was $10.2 million in Q3 2022, with the low at -$6.0 million in Q2 2020.
- Average Long-Term Debt Issuances over 3 years is $5.1 million, with a median of $8.2 million recorded in 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 19.86 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 11.71 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 1.15 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 10.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Sep 30, 2022 | 10.23 Mn |
| Sep 30, 2022 | 10.23 Mn |
| Jun 30, 2020 | -6.00 Mn |
| Jun 30, 2020 | -6.00 Mn |
| Mar 31, 2020 | 6.30 Mn |
| Mar 31, 2020 | 6.30 Mn |